---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-016696"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2022-06-09T23:59:59+00:00"
generated_at: "2026-06-25T03:06:15.227102+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ChromaDex founder Frank Jaksch resigns as executive director and employee; remains chairman

## Summary
- Frank L. Jaksch, Jr. resigns as executive director and employee effective June 30, 2022.
- He will continue to serve on the Board as Chairman of the Board.
- Resignation also covers all officer, employee, director roles at subsidiaries.
- Company is ChromaDex Corporation (CDXC).

## SEC filing metadata
- accession: 0001628280-22-016696
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2022-06-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828022016696/0001628280-22-016696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828022016696/cdxc-20220603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-016696
- JSON: https://secwatch.observer/filing/0001628280-22-016696.json
- Plain text: https://secwatch.observer/filing/0001628280-22-016696.txt

## Key facts
- Executive change
  Frank L. Jaksch, Jr. resigned as Executive Director at Niagen Bioscience, Inc..
  - Action: resigned
  - Role: Executive Director
  source text: On June 3, 2022, Frank L. Jaksch, Jr. notified ChromaDex Corporation (the “Company”) of his intention to resign as executive director and employee of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1386570/000162828022016696/0001628280-22-016696-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.